Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in ...

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

CHICAGO, July 20 (Reuters) - Medtronic Inc has agreed to pay more than $75 million to settle lawsuits claiming it hid defects in its implantable cardioverter defibrillators, better known as ICDs, ...

Medtronic MDT recently declared the findings of its investigational Extravascular Implantable Cardioverter–Defibrillator (EV ICD) Study. These were presented as late-breaking science at Heart Rhythm ...

The first-of-its-kind Aurora EV-ICD system offers a single-device, single procedure with a lead placed outside of the heart and veins. The FDA has approved the Aurora Extravascular Implantable ...

CHICAGO, Nov 19 (Reuters) - Medtronic Inc. on Monday said quarterly net earnings fell 2 percent from a year ago after its decision to stop selling a faulty component used with its implantable heart ...

(RTTNews) - Medtronic plc (MDT) said that its investigational EV ICD System - a defibrillator with the lead placed under the breastbone, outside of the heart and veins - achieved a defibrillation ...